St. Louis, Feb. 18, 2009 — Each year in the United States, doctors start about 2 million patients on warfarin (Coumadin™), an anticoagulant drug that's notoriously hard to administer. Now a study from ...

Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with ...

Daily warfarin dosing requirements clearly decrease with advancing age. To examine the relation between age and warfarin dosing, researchers analyzed data from 101 U.S. sites that were participating ...

In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of the trickiest issues in prescribing medicine—how to quickly optimize ...

Pharmacist, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan Strategies to minimize interactions between warfarin and enteral feedings have been evaluated.

Warfarin is a derivative of coumarin which interferes with the cyclic interconversion of vitamin K and its epoxide. Vitamin K is an important factor in the normal function of the coagulation system.